Share Placement raises $2.15 Million
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- R&D tax offset refund
- European Patent Granted
- Core patent granted in Australia
- New Patent to Discover Sophisticated Cell Penetrating Drugs
- Entitlement Issue and Note Conversion
Later from PYC Therapeutics
- Phylogica Accesses Novel Half-Life Extension Technology
- Phylogica - New Potential For Treating Brain Injury
- Phylogica Signs Agreement with MedImmune / AstraZeneca
- R&D Tax Rebate
- Cell-Penetrating Phylomers Improve Delivery of Drugs
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics